HURCO COMPANIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HURCO COMPANIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $178.55M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $186.58M | Jan 9, 2026 |
| FY2023 | Oct 31, 2023 | $66.11M | Jan 5, 2024 |
| FY2023 | Jul 31, 2023 | $53.20M | Jan 5, 2024 |
| FY2023 | Apr 30, 2023 | $53.82M | Jan 5, 2024 |
| FY2023 | Jan 31, 2023 | $54.68M | Jan 5, 2024 |
| FY2023 | Oct 31, 2022 | $63.46M | Jan 5, 2024 |
| FY2023 | Jul 31, 2022 | $57.64M | Jan 5, 2024 |
| FY2023 | Apr 30, 2022 | $62.83M | Jan 5, 2024 |
| FY2023 | Jan 31, 2022 | $66.89M | Jan 5, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $75.93M | Jan 5, 2018 |
| FY2017 | Jul 31, 2017 | $60.77M | Jan 5, 2018 |
| FY2017 | Apr 30, 2017 | $58.22M | Jan 5, 2018 |
| FY2017 | Jan 31, 2017 | $48.74M | Jan 5, 2018 |
| FY2017 | Oct 31, 2016 | $66.35M | Jan 5, 2018 |
| FY2017 | Jul 31, 2016 | $52.40M | Jan 5, 2018 |
| FY2017 | Apr 30, 2016 | $52.03M | Jan 5, 2018 |
| FY2017 | Jan 31, 2016 | $56.50M | Jan 5, 2018 |
| FY2016 | Oct 31, 2015 | $65.69M | Jan 6, 2017 |
| FY2016 | Jul 31, 2015 | $52.54M | Jan 6, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $32.98M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $37.74M | Jan 9, 2026 |
| FY2023 | Oct 31, 2023 | $17.42M | Jan 5, 2024 |
| FY2023 | Jul 31, 2023 | $13.45M | Jan 5, 2024 |
| FY2023 | Apr 30, 2023 | $12.58M | Jan 5, 2024 |
| FY2023 | Jan 31, 2023 | $12.72M | Jan 5, 2024 |
| FY2023 | Oct 31, 2022 | $17.57M | Jan 5, 2024 |
| FY2023 | Jul 31, 2022 | $14.40M | Jan 5, 2024 |
| FY2023 | Apr 30, 2022 | $15.60M | Jan 5, 2024 |
| FY2023 | Jan 31, 2022 | $16.91M | Jan 5, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | ($15.12M) | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | ($16.61M) | Jan 9, 2026 |
| FY2023 | Oct 31, 2023 | $2.42M | Jan 5, 2024 |
| FY2023 | Jul 31, 2023 | $260.0K | Jan 5, 2024 |
| FY2023 | Apr 30, 2023 | $377.0K | Jan 5, 2024 |
| FY2023 | Jan 31, 2023 | $1.33M | Jan 5, 2024 |
| FY2023 | Oct 31, 2022 | $1.42M | Jan 5, 2024 |
| FY2023 | Jul 31, 2022 | $1.24M | Jan 5, 2024 |
| FY2023 | Apr 30, 2022 | $2.03M | Jan 5, 2024 |
| FY2023 | Jan 31, 2022 | $3.54M | Jan 5, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | ($10.27M) | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | ($8.29M) | Jan 9, 2026 |
| FY2023 | Oct 31, 2023 | $3.38M | Jan 5, 2024 |
| FY2023 | Jul 31, 2023 | $1.01M | Jan 5, 2024 |
| FY2023 | Apr 30, 2023 | $991.0K | Jan 5, 2024 |
| FY2023 | Jan 31, 2023 | $1.23M | Jan 5, 2024 |
| FY2023 | Oct 31, 2022 | $2.70M | Jan 5, 2024 |
| FY2023 | Jul 31, 2022 | $1.75M | Jan 5, 2024 |
| FY2023 | Apr 30, 2022 | $3.09M | Jan 5, 2024 |
| FY2023 | Jan 31, 2022 | $5.21M | Jan 5, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.00M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $3.90M | Jan 9, 2026 |
| FY2025 | Oct 31, 2023 | $4.20M | Jan 9, 2026 |
| FY2024 | Oct 31, 2022 | $3.40M | Jan 10, 2025 |
| FY2023 | Oct 31, 2021 | $3.20M | Jan 5, 2024 |
| FY2022 | Oct 31, 2020 | $3.50M | Jan 6, 2023 |
| FY2021 | Oct 31, 2019 | $4.40M | Jan 7, 2022 |
| FY2020 | Oct 31, 2018 | $4.70M | Jan 8, 2021 |
| FY2019 | Oct 31, 2017 | $4.20M | Jan 3, 2020 |
| FY2018 | Oct 31, 2016 | $4.90M | Jan 4, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $43.25M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $46.03M | Jan 9, 2026 |
| FY2023 | Oct 31, 2023 | $14.04M | Jan 5, 2024 |
| FY2023 | Jul 31, 2023 | $12.44M | Jan 5, 2024 |
| FY2023 | Apr 30, 2023 | $11.59M | Jan 5, 2024 |
| FY2023 | Jan 31, 2023 | $11.48M | Jan 5, 2024 |
| FY2023 | Oct 31, 2022 | $14.87M | Jan 5, 2024 |
| FY2023 | Jul 31, 2022 | $12.65M | Jan 5, 2024 |
| FY2023 | Apr 30, 2022 | $12.52M | Jan 5, 2024 |
| FY2023 | Jan 31, 2022 | $11.70M | Jan 5, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $17.56M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | ($2.52M) | Jan 9, 2026 |
| FY2025 | Oct 31, 2023 | ($12.82M) | Jan 9, 2026 |
| FY2024 | Oct 31, 2022 | ($3.97M) | Jan 10, 2025 |
| FY2023 | Oct 31, 2021 | $32.18M | Jan 5, 2024 |
| FY2022 | Oct 31, 2020 | $10.93M | Jan 6, 2023 |
| FY2021 | Oct 31, 2019 | ($6.41M) | Jan 7, 2022 |
| FY2020 | Oct 31, 2018 | $21.01M | Jan 8, 2021 |
| FY2019 | Oct 31, 2017 | $30.37M | Jan 3, 2020 |
| FY2018 | Oct 31, 2016 | ($6.72M) | Jan 4, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $910.0K | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $1.24M | Jan 9, 2026 |
| FY2025 | Oct 31, 2023 | $1.29M | Jan 9, 2026 |
| FY2024 | Oct 31, 2022 | $1.11M | Jan 10, 2025 |
| FY2023 | Oct 31, 2021 | $1.26M | Jan 5, 2024 |
| FY2022 | Oct 31, 2020 | $683.0K | Jan 6, 2023 |
| FY2021 | Oct 31, 2019 | $3.17M | Jan 7, 2022 |
| FY2020 | Oct 31, 2018 | $3.54M | Jan 8, 2021 |
| FY2019 | Oct 31, 2017 | $2.18M | Jan 3, 2020 |
| FY2018 | Oct 31, 2016 | $1.97M | Jan 4, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $264.30M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $268.64M | Jan 9, 2026 |
| FY2024 | Oct 31, 2023 | $290.59M | Jan 10, 2025 |
| FY2023 | Oct 31, 2022 | $306.24M | Jan 5, 2024 |
| FY2022 | Oct 31, 2021 | $332.94M | Jan 6, 2023 |
| FY2021 | Oct 31, 2020 | $295.66M | Jan 7, 2022 |
| FY2020 | Oct 31, 2019 | $301.07M | Jan 8, 2021 |
| FY2019 | Oct 31, 2018 | $315.41M | Jan 3, 2020 |
| FY2018 | Oct 31, 2017 | $277.81M | Jan 4, 2019 |
| FY2017 | Oct 31, 2016 | $251.95M | Jan 5, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $198.79M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $207.17M | Jan 9, 2026 |
| FY2025 | Oct 31, 2023 | $222.23M | Jan 9, 2026 |
| FY2025 | Oct 31, 2022 | $222.64M | Jan 9, 2026 |
| FY2024 | Oct 31, 2021 | $238.42M | Jan 10, 2025 |
| FY2023 | Oct 31, 2020 | $231.15M | Jan 5, 2024 |
| FY2022 | Oct 31, 2019 | $240.25M | Jan 6, 2023 |
| FY2021 | Oct 31, 2018 | $222.85M | Jan 7, 2022 |
| FY2020 | Oct 31, 2017 | $203.09M | Jan 8, 2021 |
| FY2019 | Oct 31, 2016 | $185.48M | Jan 3, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Oct 31, 2023 | $0 | Jan 5, 2024 |
| FY2020 | Oct 31, 2020 | $0 | Jan 8, 2021 |
| FY2020 | Oct 31, 2019 | $5.85M | Jan 8, 2021 |
| FY2019 | Aug 5, 2019 | $3.50M | Jan 3, 2020 |
| FY2021 | May 8, 2019 | $2.50M | Jan 7, 2022 |
| FY2019 | Oct 31, 2018 | $2.38M | Jan 3, 2020 |
| FY2018 | Oct 31, 2017 | $2.44M | Jan 4, 2019 |
| FY2017 | Oct 31, 2016 | $2.31M | Jan 5, 2018 |
| FY2016 | Oct 31, 2015 | $2.32M | Jan 6, 2017 |
| FY2015 | Oct 31, 2014 | $2.61M | Jan 8, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $146.31M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $161.42M | Jan 9, 2026 |
| FY2024 | Oct 31, 2023 | $180.12M | Jan 10, 2025 |
| FY2023 | Oct 31, 2022 | $179.88M | Jan 5, 2024 |
| FY2022 | Oct 31, 2021 | $175.57M | Jan 6, 2023 |
| FY2021 | Oct 31, 2020 | $172.48M | Jan 7, 2022 |
| FY2020 | Oct 31, 2019 | $182.15M | Jan 8, 2021 |
| FY2019 | Oct 31, 2018 | $167.86M | Jan 3, 2020 |
| FY2018 | Oct 31, 2017 | $149.27M | Jan 4, 2019 |
| FY2017 | Oct 31, 2016 | $136.74M | Jan 5, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $48.71M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | $33.33M | Jan 9, 2026 |
| FY2024 | Oct 31, 2023 | $41.78M | Jan 10, 2025 |
| FY2023 | Oct 31, 2022 | $63.92M | Jan 5, 2024 |
| FY2022 | Oct 31, 2021 | $84.06M | Jan 6, 2023 |
| FY2021 | Oct 31, 2020 | $57.86M | Jan 7, 2022 |
| FY2020 | Oct 31, 2019 | $56.94M | Jan 8, 2021 |
| FY2020 | Oct 31, 2018 | $77.17M | Jan 8, 2021 |
| FY2020 | Oct 31, 2017 | $66.31M | Jan 8, 2021 |
| FY2019 | Oct 31, 2016 | $41.22M | Jan 3, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | (2) | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | (2) | Jan 9, 2026 |
| FY2023 | Oct 31, 2023 | 0 | Jan 5, 2024 |
| FY2023 | Jul 31, 2023 | 0 | Jan 5, 2024 |
| FY2023 | Apr 30, 2023 | 0 | Jan 5, 2024 |
| FY2023 | Jan 31, 2023 | 0 | Jan 5, 2024 |
| FY2023 | Oct 31, 2022 | 0 | Jan 5, 2024 |
| FY2023 | Jul 31, 2022 | 0 | Jan 5, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Jan 5, 2024 |
| FY2023 | Jan 31, 2022 | 0 | Jan 5, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | (2) | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | (2) | Jan 9, 2026 |
| FY2023 | Oct 31, 2023 | 0 | Jan 5, 2024 |
| FY2023 | Jul 31, 2023 | 0 | Jan 5, 2024 |
| FY2023 | Apr 30, 2023 | 0 | Jan 5, 2024 |
| FY2023 | Jan 31, 2023 | 0 | Jan 5, 2024 |
| FY2023 | Oct 31, 2022 | 0 | Jan 5, 2024 |
| FY2023 | Jul 31, 2022 | 0 | Jan 5, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Jan 5, 2024 |
| FY2023 | Jan 31, 2022 | 0 | Jan 5, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 6.40M | Jan 9, 2026 |
| FY2025 | Oct 31, 2024 | 6.44M | Jan 9, 2026 |
| FY2024 | Oct 31, 2023 | 6.46M | Jan 10, 2025 |
| FY2023 | Oct 31, 2022 | 6.57M | Jan 5, 2024 |
| FY2022 | Oct 31, 2021 | 6.62M | Jan 6, 2023 |
| FY2021 | Oct 31, 2020 | 6.57M | Jan 7, 2022 |
| FY2020 | Oct 31, 2019 | 6.77M | Jan 8, 2021 |
| FY2019 | Oct 31, 2018 | 6.72M | Jan 3, 2020 |
| FY2018 | Oct 31, 2017 | 6.64M | Jan 4, 2019 |
| FY2017 | Oct 31, 2016 | 6.57M | Jan 5, 2018 |